PRELUDE THERAPEUTICS INC
PRLD·74065P101·US·Common Stock·Healthcare - Biotechnology-Activist
PRLD (PRELUDE THERAPEUTICS INC) is held by 41 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($34.6M), VANGUARD CAPITAL MANAGEMENT LLC ($4.2M), TWO SIGMA INVESTMENTS, LP ($3.2M). Net institutional sentiment: Bullish.
41
Holders
Avg rating(6 Elite)
$54.5M
Total Value
71% (44)
Fund Consensus
25 buying - 10 selling
Who's Trading
ActivistSOSoleus Capital Management, L.P.5.2%Jul 8, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Other 1.4M shApr 27, 2026
ActivistOAORBIMED ADVISORS LLC16.0%Apr 23, 2026
InsiderBPBonita David PBuy $7.5MApr 21, 2026
InsiderOLORBIMED ADVISORS LLCBuy $7.5MApr 21, 2026
InsiderOLORBIMED ADVISORS LLCBuy $5.0MApr 21, 2026
InsiderBPBonita David PBuy $5.0MApr 21, 2026
ActivistVKVaddi Krishna13.2%Feb 13, 2026
13F: Insider & Congress:
Showing 1-20 of 44
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer